Term ends Dec 20, 2032 · Low confidence
20-year base term ends Dec 20, 2032
Held by Lakefront Biotherapeutics
Filed Dec 11, 2015 as application 14/966,879 · Granted Aug 14, 2018
Base term, 20 years from filing
Today
2012
2032
Clock starts
Dec 20, 2012
Dec 20, 2012
Term ends
Dec 20, 2032
Dec 20, 2032
Granted
Aug 14, 2018
Aug 14, 2018
base term
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,927,543, US 9,255,095, to Dec 20, 2032. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 20, 2012, when application 13/721,788, the earliest non-provisional in its chain, was filed (this one was filed Dec 11, 2015); a parent in its chain could not be resolved (the next row) | Dec 20, 2032 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,927,543, US 9,255,095) | resolves to Dec 20, 2032, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: 14148057, 13721788 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Dec 20, 2032 | Low confidence |
This family
| US 8,927,543 | In force Dec 2032 | Dec 2032 |
| US 9,255,095 | In force Dec 2032 | Dec 2032 |
| US 10,047,083 | this patent Dec 2032 | Dec 2032 |
| US 11,220,499 | In force Dec 2032 | Dec 2032 |
| Application 17/454,712 | Abandoned not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 14, 2015 Reel 37285, frame 156 | Labéguère, Frédéric Gilbert; Newsome, Gregory John Robert; Alvey, Luke Jonathan; Sanière, Laurent Raymond Maurice; Fletcher, Stephen Robert; Galapagos Sasu | Galapagos N.V. | Assignment of Assignor's Interest |
| Aug 23, 2019 Reel 50149, frame 161 | Galapagos N.V. | Gilead Sciences, Inc. | Security Interest |
| Feb 15, 2022 Reel 59020, frame 871 | Gilead Sciences, Inc. | Galapagos N.V. | Release of Security Interest |
| Jun 4, 2026 Reel 74845, frame 68 | Galapagos | Lakefront Biotherapeutics | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Dec 2032
Term ends Dec 20, 2032. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 8,927,543, US 9,255,095, ends no earlier than this term, so it caps nothing.
Citations
3
later US patents cite this one
That is below the median of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.